2017 American Transplant Congress

Tuesday, May 2, 2017

5:30pm-5:42pm

Optimization of Pancreatic Islet-Like Clusters from hiPSCs for Cell Therapy in Type 1 Diabetes.

G. Pettinato, P. Kyriazis, M. Thompson, M. Koulmanda, R. Fisher.

Concurrent Session: Islet Transplant  •  E352

5:30pm-5:42pm

Outcomes of Organs Transplants When the Donor Is a Prior Recipient.

G. Lee,¹ D. Goldberg,² M. Levine,¹ P. Abt.¹

Concurrent Session: Economics and Outcomes in Organ Transplantation  •  E271a

5:30pm-5:42pm

Prolonged Dialysis Prior to Renal Transplantation.

D. Aufhauser Jr,¹ A. Peng,¹ D. Murken,¹ S. Concors,¹ M. Levine.^1,2

Concurrent Session: Long Term Kidney Graft Survival II  •  E450a

5:30pm-5:42pm

Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

B.-H. Shin,¹ S. Ge,¹ J. Mirocha,² D. Thomas,¹ E. Rodriguez,¹ C. Chao,¹ O. Galera,¹ A. Vo,¹ J. Choi,¹ A. Peng,¹ J. Kahwaji,¹ S. Jordan,¹ M. Toyoda.¹

Concurrent Session: PTLD  •  E271b

5:30pm-5:42pm

The Combined Effects of Induction Regimens and Antiviral Prophylaxis on the Risk of CMV Infection in Different Serostatus Subgroups After Liver Transplantation.

C. Low,² S. Hosseini-Moghaddam,^1,2 C. Rotstein,² E. Renner,² A. Humar,² D. Kumar,² S. Husain.²

Concurrent Session: Liver: Immunosuppression and Rejection  •  E451b

5:30pm-5:42pm

Use of Hepatitis C Infected Organs for Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd,¹ K. Doucette,² K. Tennankore.¹

Concurrent Session: DCD and Infectious Risk Kidney Donors  •  E450b

5:42pm-5:54pm

A Phase-Two, Randomised, Placebo-Controlled Trial: Belimumab in Renal Transplantation Targets Naïve, Activated Memory and Antibody Producing B Cells Whilst Sparing Regulatory B Cells.

G. Banham,^1,2 S. Flint,³ N. Torpey,² P. Lyons,¹ D. Shanahan,³ A. Gibson,³ A.-M. O'Sullivan,² R. Jones,^1,2,3 L. Devey,³ A. Richards,³ L. Erwig,³ C. Savage,³ K. Smith,^1,2 R. Henderson,³ M. Clatworthy.^1,2

Concurrent Session: Novel Immunosuppression Regimens - Belatacept  •  E354b

5:42pm-5:54pm

Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

J. Levitsky,¹ T. Whisenant,² S. Kurian,² S. Rao,¹ A. Demetris,³ M. Abecassis.¹

Concurrent Session: Late Breaking  •  E353C

5:42pm-5:54pm

Delayed Graft Function and Long-Term Graft Survival in DBD and DCD Kidney Recipients.

A. Massie, D. Segev.

Concurrent Session: DCD and Infectious Risk Kidney Donors  •  E450b

5:42pm-5:54pm

Dramatic Shifts in Prognosis, Outcomes and Baseline Risk Among Wait Listed Kidney Transplant Candidates in the United States.

J. Schold, E. Poggio, L. Buccini, S. Flechner, J. Augustine, D. Goldfarb.

Concurrent Session: Disparities in Kidney Transplantation  •  E451a